Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pyrimidine derivatives from Roche for psychotic disorders

May 26, 1997

No Comments

5-HT reuptake inhibitors disclosed by NeuroSearch

May 26, 1997

No Comments

MAO-A and/or MAO-B inhibitors described by Synthelabo

May 26, 1997

No Comments

EAA antagonists reported by Pharmacia & Upjohn

May 26, 1997

No Comments

FUB-181: Potent and selective H3 antagonist

May 23, 1997

No Comments

OPC-14117 effective in mouse model of motor neuron disease

May 23, 1997

No Comments

Cortex to evaluate CX-516 for the treatment of schizophrenia

May 23, 1997

No Comments

Results from a comparative study of olanzapine and risperidone reported

May 22, 1997

No Comments

First launch for Quadramet

May 22, 1997

No Comments

NMDA antagonist/opiate combination provides superior analgesia to morphine alone

May 22, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Pyrimidine derivatives from Roche for psychotic disorders

5-HT reuptake inhibitors disclosed by NeuroSearch

MAO-A and/or MAO-B inhibitors described by Synthelabo

EAA antagonists reported by Pharmacia & Upjohn

FUB-181: Potent and selective H3 antagonist

OPC-14117 effective in mouse model of motor neuron disease

Cortex to evaluate CX-516 for the treatment of schizophrenia

Results from a comparative study of olanzapine and risperidone reported

First launch for Quadramet

NMDA antagonist/opiate combination provides superior analgesia to morphine alone

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS